Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Antimicrob Resist Infect Control ; 10(1): 44, 2021 02 27.
Artigo em Inglês | MEDLINE | ID: mdl-33640031

RESUMO

The proportion of asymptomatic carriers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains elusive and the potential benefit of systematic screening during the SARS-CoV-2-pandemic is controversial. We investigated the proportion of asymptomatic inpatients who were identified by systematic screening for SARS-CoV-2 upon hospital admission. Our analysis revealed that systematic screening of asymptomatic inpatients detects a low total number of SARS-CoV-2 infections (0.1%), questioning the cost-benefit ratio of this intervention. Even when the population-wide prevalence was low, the proportion of asymptomatic carriers remained stable, supporting the need for universal infection prevention and control strategies to avoid onward transmission by undetected SARS-CoV-2-carriers during the pandemic.


Assuntos
Infecções Assintomáticas/epidemiologia , COVID-19/diagnóstico , SARS-CoV-2/isolamento & purificação , Idoso , COVID-19/epidemiologia , COVID-19/transmissão , Teste para COVID-19/economia , Teste para COVID-19/métodos , Análise Custo-Benefício , Feminino , Humanos , Masculino , Programas de Rastreamento/economia , Programas de Rastreamento/métodos , Pessoa de Meia-Idade , Suíça/epidemiologia
2.
Influenza Other Respir Viruses ; 14(1): 72-76, 2020 01.
Artigo em Inglês | MEDLINE | ID: mdl-31651074

RESUMO

We report an influenza outbreak in a 75-bed rehabilitation centre and present the detailed microeconomic impact that it had during the season 2016/2017. The direct medical, direct non-medical and indirect costs were calculated. The outbreak included 18 patients with influenza and 8 contact patients, leading to 86 days with isolation precautions. During the outbreak month, 25 (15%) employees were absent from work for 89 days (mean 3.6 days, SD ± 1.8), and during the entire influenza season 33 for 175 (5.3 ± SD 4.6) days, respectively. The economic burden related to the outbreak was 114 373 CHF (106 890 €, 112 131 $).


Assuntos
Efeitos Psicossociais da Doença , Influenza Humana/epidemiologia , Centros de Reabilitação/economia , Surtos de Doenças , Hospitalização/economia , Humanos , Influenza Humana/economia , Centros de Reabilitação/estatística & dados numéricos , Suíça
3.
Infect Control Hosp Epidemiol ; 40(9): 1063-1065, 2019 09.
Artigo em Inglês | MEDLINE | ID: mdl-31309908

RESUMO

Health insurance status may affect the risk for surgical site infection (SSI). A large prospective cohort study in a Swiss tertiary-care hospital did not find evidence of a difference in SSI risk in individuals with basic versus semiprivate or private insurance in a setting with universal health insurance coverage.


Assuntos
Cobertura do Seguro/estatística & dados numéricos , Seguro Saúde/estatística & dados numéricos , Infecção da Ferida Cirúrgica/epidemiologia , Idoso , Feminino , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Fatores de Risco , Suíça/epidemiologia
5.
Infect Control Hosp Epidemiol ; 39(1): 101-103, 2018 01.
Artigo em Inglês | MEDLINE | ID: mdl-29249218

RESUMO

We prospectively evaluated direct costs of contact precautions using on-site observation. Additional mean costs per patient day were calculated for extra materials used, increased workload, and one-off isolation activities. The cost of contact precautions was $158.90 (95% confidence interval, $124.90‒$192.80) per patient day. Infect Control Hosp Epidemiol 2018;39:101-103.


Assuntos
Infecção Hospitalar/economia , Custos Hospitalares , Controle de Infecções/economia , Custos e Análise de Custo , Hospitais Universitários , Humanos , Isolamento de Pacientes/economia , Estudos Prospectivos , Suíça
6.
J Antimicrob Chemother ; 72(11): 3205-3212, 2017 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-28961815

RESUMO

OBJECTIVES: To assess the quality of antibiotic prescribing of Swiss primary care physicians with high prescription rates. METHODS: In January 2015, we mailed a structured questionnaire to 2900 primary care physicians in Switzerland. They were included in a nationwide pragmatic randomized controlled trial on routine antibiotic prescription monitoring and feedback based on health insurance claims data. We asked them to record the diagnosis and antibiotic treatment for 44 consecutive patients with the most common conditions associated with antibiotic prescribing in primary care. We evaluated if the disease-specific antibiotic prescribing and the proportion of non-recommended antibiotics used, in particular quinolones, were within 'acceptable ranges' using adapted European Surveillance of Antimicrobial Consumption (ESAC) quality indicators. RESULTS: Two hundred and fifty physicians (8.6%) responded, providing 9961 patient records. Responders were similar to the entire physician population. Overall, antibiotics were prescribed to 32.1% of patients. For tonsillitis/pharyngitis, acute otitis media, acute rhinosinusitis and acute bronchitis the acceptable maximum of antibiotic prescriptions was exceeded by 24.4%, 49.6%, 27.4% and 11.5%, respectively. The proportion of non-recommended antibiotics was for all diagnoses above the recommended maximum of 20% (31.5%-88.7% across all conditions). Quinolones were prescribed to 37.2% of women with urinary tract infections, substantially exceeding the recommended maximum of 5%. CONCLUSIONS: Antibiotic prescribing quality of Swiss primary care physicians with high prescription rates is low according to the indicators used, with substantial overtreatment of tonsillitis/pharyngitis, acute rhinosinusitis, acute otitis media and acute bronchitis. Routine nationwide and continuous monitoring of antibiotic use and specific interventions are warranted to improve prescribing in primary care.


Assuntos
Antibacterianos/uso terapêutico , Prescrições de Medicamentos/normas , Prescrição Inadequada , Padrões de Prática Médica/normas , Atenção Primária à Saúde/normas , Doença Aguda , Adolescente , Adulto , Idoso , Feminino , Fidelidade a Diretrizes , Humanos , Masculino , Pessoa de Meia-Idade , Otite Média/tratamento farmacológico , Indicadores de Qualidade em Assistência à Saúde , Infecções Respiratórias/tratamento farmacológico , Inquéritos e Questionários , Suíça/epidemiologia , Infecções Urinárias/tratamento farmacológico , Adulto Jovem
7.
Infect Control Hosp Epidemiol ; 38(1): 18-23, 2017 01.
Artigo em Inglês | MEDLINE | ID: mdl-27745555

RESUMO

BACKGROUND Infections and colonization with multidrug-resistant organisms (MDROs) identified >48 hours after hospital admission are considered healthcare-acquired according to the definition of the Centers for Disease Control and Prevention (CDC). Some may originate from delayed diagnosis rather than true acquisition in the hospital, potentially diluting the impact of infection control programs. In addition, such infections are not necessarily reimbursed in a healthcare system based on the diagnosis-related groups (DRGs). OBJECTIVE The goal of the study was to estimate the preventable proportion of healthcare-acquired infections in a tertiary care hospital in Switzerland by analyzing patients colonized or infected with MDROs. METHODS All hospitalized patients with healthcare-acquired MDRO infection or colonization (HAMIC) or according to the CDC definition (CDC-HAMIC) were prospectively assessed from 2002 to 2011 to determine whether there was evidence for nosocomial transmission. We utilized an additional work-up with epidemiological, microbiological, and molecular typing data to determine the true preventable proportion of HAMICs. RESULTS Overall, 1,190 cases with infection or colonization with MDROs were analyzed; 274 (23.0%) were classified as CDC-HAMICs. Only 51.8% of CDC-HAMICs had confirmed evidence of hospital-acquisition and were considered preventable. Specifically, 57% of MRSA infections, 83.3% of VRE infections, 43.9% of ESBL infections, and 74.1% of non-ESBL MDRO infections were preventable HAMICs. CONCLUSIONS The CDC definition overestimates the preventable proportion of HAMICs with MDROs by more than 50%. Relying only on the CDC definition of HAMICs may lead to inaccurate measurement of the impact of infection control interventions and to inadequate reimbursement under the DRG system. Infect. Control Hosp. Epidemiol. 2016;1-6.


Assuntos
Infecção Hospitalar/epidemiologia , Grupos Diagnósticos Relacionados/estatística & dados numéricos , Infecções Estafilocócicas/epidemiologia , Viroses/epidemiologia , Idoso , Idoso de 80 Anos ou mais , Anti-Infecciosos/uso terapêutico , Resistência Microbiana a Medicamentos/efeitos dos fármacos , Feminino , Hospitalização , Humanos , Controle de Infecções/métodos , Masculino , Pessoa de Meia-Idade , Suíça/epidemiologia , Centros de Atenção Terciária
8.
Swiss Med Wkly ; 144: w14009, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25250957

RESUMO

Most hospital-acquired infections arise from colonising bacteria. Intensive care patients and immunocompromised individuals are at highest risk for microbial invasion and subsequent infection due to multiple invasive procedures in addition to frequent application of chemotherapeutics and presence of poor microperfusion leading to mucosal disruption. In this narrative review, we summarise the literature on bacterial colonisation in intensive care patients, in particular the epidemiology, the clinical impact and respective infection control strategies of three pathogens, i.e., Enterococcus spp., extended-spectrum ß-lactamase producing gram-negative bacteria and Clostridium difficile, which have evolved from commensals to a public health concern today.


Assuntos
Infecções Bacterianas/epidemiologia , Infecções Bacterianas/prevenção & controle , Infecção Hospitalar/epidemiologia , Infecção Hospitalar/prevenção & controle , Unidades de Terapia Intensiva , Fatores Etários , Vacinas Bacterianas , Clorexidina , Clostridioides difficile , Farmacorresistência Bacteriana Múltipla , Enterococcus , Bactérias Gram-Negativas , Mortalidade Hospitalar , Humanos , Controle de Infecções/organização & administração , Testes de Sensibilidade Microbiana , Prevalência , Fatores de Risco , beta-Lactamases
9.
Swiss Med Wkly ; 142: w13616, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22949137

RESUMO

INTRODUCTION: Surgical site infections (SSI) are the most common hospital-acquired infections among surgical patients, with significant impact on patient morbidity and health care costs. The Basel SSI Cohort Study was performed to evaluate risk factors and validate current preventive measures for SSI. The objective of the present article was to review the main results of this study and its implications for clinical practice and future research. SUMMARY OF METHODS OF THE BASEL SSI COHORT STUDY: The prospective observational cohort study included 6,283 consecutive general surgery procedures closely monitored for evidence of SSI up to 1 year after surgery. The dataset was analysed for the influence of various potential SSI risk factors, including timing of surgical antimicrobial prophylaxis (SAP), glove perforation, anaemia, transfusion and tutorial assistance, using multiple logistic regression analyses. In addition, post hoc analyses were performed to assess the economic burden of SSI, the efficiency of the clinical SSI surveillance system, and the spectrum of SSI-causing pathogens. REVIEW OF MAIN RESULTS OF THE BASEL SSI COHORT STUDY: The overall SSI rate was 4.7% (293/6,283). While SAP was administered in most patients between 44 and 0 minutes before surgical incision, the lowest risk of SSI was recorded when the antibiotics were administered between 74 and 30 minutes before surgery. Glove perforation in the absence of SAP increased the risk of SSI (OR 2.0; CI 1.4-2.8; p <0.001). No significant association was found for anaemia, transfusion and tutorial assistance with the risk of SSI. The mean additional hospital cost in the event of SSI was CHF 19,638 (95% CI, 8,492-30,784). The surgical staff documented only 49% of in-hospital SSI; the infection control team registered the remaining 51%. Staphylococcus aureus was the most common SSI-causing pathogen (29% of all SSI with documented microbiology). No case of an antimicrobial-resistant pathogen was identified in this series. CONCLUSIONS: The Basel SSI Cohort Study suggested that SAP should be administered between 74 and 30 minutes before surgery. Due to the observational nature of these data, corroboration is planned in a randomized controlled trial, which is supported by the Swiss National Science Foundation. Routine change of gloves or double gloving is recommended in the absence of SAP. Anaemia, transfusion and tutorial assistance do not increase the risk of SSI. The substantial economic burden of in-hospital SSI has been confirmed. SSI surveillance by the surgical staff detected only half of all in-hospital SSI, which prompted the introduction of an electronic SSI surveillance system at the University Hospital of Basel and the Cantonal Hospital of Aarau. Due to the absence of multiresistant SSI-causing pathogens, the continuous use of single-shot single-drug SAP with cefuroxime (plus metronidazole in colorectal surgery) has been validated.


Assuntos
Controle de Infecções/métodos , Infecção da Ferida Cirúrgica/prevenção & controle , Anemia/complicações , Antibacterianos/uso terapêutico , Antibioticoprofilaxia/métodos , Transfusão de Sangue/estatística & dados numéricos , Cefuroxima/uso terapêutico , Estudos de Coortes , Seguimentos , Luvas Cirúrgicas , Custos Hospitalares/estatística & dados numéricos , Humanos , Controle de Infecções/estatística & dados numéricos , Modelos Logísticos , Análise Multivariada , Cuidados Pré-Operatórios/métodos , Estudos Prospectivos , Fatores de Risco , Infecção da Ferida Cirúrgica/economia , Infecção da Ferida Cirúrgica/etiologia , Suíça , Fatores de Tempo
10.
Infect Control Hosp Epidemiol ; 29(7): 623-9, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18564917

RESUMO

OBJECTIVE: To quantify the economic burden of in-hospital surgical site infections (SSIs) at a European university hospital. DESIGN: Matched case-control study nested in a prospective observational cohort study. SETTING: Basel University Hospital in Switzerland, where an average of 28,000 surgical procedures are performed per year. METHODS: All in-hospital occurrences of SSI associated with surgeries performed between January 1, 2000, and December 31, 2001, by the visceral, vascular, and traumatology divisions at Basel University Hospital were prospectively recorded. Each case patient was matched to a control patient by age, procedure code, and National Nosocomial Infection Surveillance System risk index. The case-control pairs were analyzed for differences in cost of hospital care and in provision of specialized care. RESULTS: A total of 6,283 procedures were performed: 187 SSIs were detected in inpatients, 168 of whom were successfully matched with a control patient. For case patients, the mean additional hospital cost was SwF-19,638 (95% confidence interval [CI], SwF-8,492-SwF-30,784); the mean additional postoperative length of hospital stay was 16.8 days (95% CI, 13-20.6 days); and the mean additional in-hospital duration of antibiotic therapy was 7.4 days (95% CI, 5.1-9.6 days). Differences were primarily attributable to organ space SSIs (n = 76). CONCLUSIONS: In a European university hospital setting, SSIs are costly and constitute a heavy and potentially preventable burden on both patients and healthcare providers.


Assuntos
Infecção Hospitalar/economia , Custos Hospitalares/estatística & dados numéricos , Hospitais Universitários/economia , Infecção da Ferida Cirúrgica/economia , Antibacterianos/uso terapêutico , Estudos de Casos e Controles , Infecção Hospitalar/tratamento farmacológico , Infecção Hospitalar/epidemiologia , Infecção Hospitalar/prevenção & controle , Feminino , Hospitais Universitários/estatística & dados numéricos , Humanos , Tempo de Internação , Masculino , Infecção da Ferida Cirúrgica/tratamento farmacológico , Infecção da Ferida Cirúrgica/epidemiologia , Infecção da Ferida Cirúrgica/prevenção & controle , Suíça
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA